122.17USD+2.65%Mkt Cap: 12.87B $P/E: 264.49Today
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.59BUSD
Key Statistics
Company
Market Cap12.87B $
Enterprise Value12.79B $
Revenue (TTM)830.81M $
Gross Profit748.43M $
Net Income (TTM)99.65M $
Revenue/Share7.968 USD
Last Price122.17 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees730
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)264.49
P/E (Forward)27.50
PEG0.81
EV/EBITDA1581.71
EV/Revenue15.39
P/S15.75
P/B18.51
EPS (TTM)0.46
EPS (Forward)4.40
52W Range
28.66100% of range122.21
52W High122.21 USD
52W Low28.66 USD
Profitability
Gross Margin98.30%
Oper. Margin16.12%
EBITDA Margin0.97%
Profit Margin13.09%
ROE15.38%
ROA11.91%
Growth
Revenue Growth31.70%
Earnings Growth24.10%
Cash Flow & Leverage
Operating CF142.00M $
CapEx (TTM)211.00K $
FCF Margin9.32%
FCF Yield0.60%
Net Debt-298.78M $
Net Debt/EBITDA-36.96
Balance Sheet
Debt/Equity0.01
Current Ratio2.86
Quick Ratio2.50
Book Value/Sh6.540 USD
Cash/Share2.851 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)141.00 USD
Upside (mean)+15.4%
Target Range50.00 USD – 165.00 USD
$50.00+15.4% to mean$165.00
# Analysts5
Ownership
Shares Out.108.10M
Float96.36M
Insiders11.45%
Institutions76.92%
Short Interest
Short Ratio7.4d
Short % Float11.70%
Short % Out.9.08%
Shares Short9.82M
Short (prev mo.)8.64M
Technical
SMA 5096.42 (+26.7%)
SMA 20064.55 (+89.3%)
Beta0.46
S&P 52W Chg18.16%
Avg Vol (30d)1.15M
Avg Vol (10d)784.72K
Technical Indicators
RSI (14)68.5
MACD6.9389
MACD Signal6.8027
MACD Hist.+0.1363
BB Upper126.67 USD
BB Middle107.27 USD
BB Lower87.87 USD
BB Width36.17%
ATR (14)4.671 USD
Vol Ratio (20d)0.73x